Dompé
at a glance

RESEARCH, DEVELOPMENT AND PRODUCTION

Dompé is a privately owned biopharmaceutical company with 130 years of experience. Headquartered in Milan, we operate in Boston, San Francisco, and Shanghai. Dompé is committed to medical and scientific advancement, through our own research and open innovation ecosystem.

PRIMARY CARE

Prescription drugs and OTC products, dietary supplements, medical devices and cosmetics

BIOTECH

Treatment of rare diseases with no approved treatment

We conduct our research activities as part of a network of over 300 centers and universities across the world that has performed 27 clinical trials for more than 2000 patients.

Discover our research
Discover our production hub
head icon
THERAPEUTIC AREAS

Diabetes, Opthalmology, and conditions with high unmet need

people icon
800

Total employees

globe icon
REACH

Europe, United States, China

boxes icon
60 MILLION

Packages manufactured in 2019

productionLine icon
8

Production lines (7 synthesis, 1 biotech)

dnaBio icon
CDMO

Synthesis and biotech

certificate icon
BIOTECH APPROVALS

EMA (European Medicines Agency), Europe
FDA (Food and Drug Administration), United States
NMPA (National Medical Products Administration), China

BIOTECH

We have developed the first application of rhNGF (recombinant human Nerve Growth Factor) as a commercial therapy. Dompé's
rhNGF is the first and only pharmacologic treatment specifically indicated for Neurotrophic Keratitis, approved by the FDA and EMA.

  • 2017

    Year of marketing authorization granted by the EMA in Europe and granted breakthrough, fast track and priority review designations by FDA in the US

  • 2018

    FDA approval

  • 2019

    Chinese National Medical Products Administration (NMPA) inclusion among the 40 clinically needed drugs overseas

  • 2020

    Expected NMPA marketking authorization

Discover our biotech production
HISTORY

Dompé farmaceutici is established in 1940, stemming from a pharmacological roots dating back to the Nineteenth Century

  • 1870-1890

    Gian Antonio Dompé devotes himself to studying chemical-pharmaceutical sciences and eventually becomes a science savant.

  • 1895

    Onorato Dompé, Gian Antonio’s son, establishes the Dompé-Adami laboratory in Milan.

  • 1924

    Onorato Dompé establishes the first pharmaceutical production plant in Milan.

  • 1940

    Franco Dompé, Onorato’s son, founds Dompé farmaceutici in Milan.

Discover our full story

Dompé Farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153